Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Muscular Dystrophy, Duchenne
Interventions
OTHER

Cardiac MRI with contrast

Cardiac MRI

OTHER

Cardiac MRI without contrast

Cardiac MRI

OTHER

Blood Test

Hematocrit, Creatinine, Troponin, BNP

OTHER

Heart Rate

Holter Monitor

OTHER

Pulmonary Function Test

Pulmonary Function Test

OTHER

Genetic Testing

Genetic Testing

OTHER

Repeat MRI scan

Repeat MRI scan

Trial Locations (3)

90024

University of California, Los Angeles, Los Angeles

92868

Children's Hospital of Orange County, Orange

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Children's Hospital of Orange County

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University of California, Los Angeles

OTHER

lead

Stanford University

OTHER

NCT02834650 - Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD | Biotech Hunter | Biotech Hunter